The COMPASS PGx Study
Enrollment options
This training is designed to address, with pharmacogenomic testing, the selection of selective serotonin reuptake inhibitor antidepressants that are first line options in the treatment of depression. This training will teach the ethics and basics of PGx-guided depression treatment, specifically in the setting of community pharmacies conducting clinical research. Additionally, this training will cover ways to enhance comprehensive medication reviews conducted by pharmacists to improve PGx-guided depression treatment.
PLANNING COMMITTEE
 |
Samantha Bailey, PharmD PhD Candidate University of Pittsburgh School of Pharmacy |
 |
Lucas Berenbrok, PharmD, MS, BCACP, FAPhA Vice Chair for Education Associate Professor, Pharmacy and Therapeutics University of Pittsburgh School of Pharmacy |
 |
Kim Coley, PharmD Professor, Pharmacy and Therapeutics University of Pittsburgh School of Pharmacy |
 |
Philip Empey, PharmD, PhD, FCCP Associate Professor, Pharmacy and Therapeutics Associate Director, Institute of Precision Medicine University of Pittsburgh School of Pharmacy |
 |
Mylynda Massart MD, PhD Associate Professor, Department of Family Medicine Primary Care Precision Medicine University of Pittsburgh |
CONFLICT OF INTEREST
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
SELF-PACED, ONLINE STUDY
TARGET AUDIENCE
This course is aimed to target a specific group of community-based pharmacists who will be implementing PGx-guided medication management visits for research participants whoa re taking medication(s) to treat their depression.
LEARNING MODULES
- The importance and value of good research ethics
- PGx in clinical practice: treatment of depression
- Interpretation of results
- Returning results to patients
LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:- Describe how pharmacogenomic (PGx) variation affects the toxicity and efficacy of antidepressants in the context of depressive disorders
- Analyze and interpret PGx test results utilizing CPIC guidelines for SSRIs
- Discuss clinical decision-making in PGx including phenoconversion and drug-drug interactions
- Explore best practices for returning PGx test results to patients and documentation of PGx test results
DISCLAIMER STATEMENT
The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical education (ACCME), Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.5 contact hours of continuing pharmacy education credit. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Continuing education can be claimed for the above learner groups. Learners must complete the full program (view all modules and attain a grade of 80% or higher on the assessment) as well as submit the required information to the CE office (e.g., profile information and evaluations) prior to the deadline to receive continuing education credit. Partial credit will not be awarded.ACCREDITATION
HOW TO OBTAIN CONTINUING EDUCATION